Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “combination”

418 pharma patents match "combination" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 418
Index total 30,257
Page 13 / 18

Quick answer

This filtered view shows 418 pharmaceutical patents matching "combination" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

418 results for “combination” · 30,257 patents in full index Clear search

  1. US 9629899

    Targeted cargo protein combination therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  2. US 9597302

    Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation

    Heart Rhythm Solutions, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  3. US 9572809

    Combination therapy to treat Mycobacterium diseases

    SPERO TRINEM, INC. · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted

  4. US 9561245

    Combination treatments for melanoma

    The Board of Regents of the University of Texas System · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

  5. US 9556113

    Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment

    SOUTH DAKOTA BOARD OF REGENTS · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  6. US 9532994

    Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins

    The Regents of the University of California · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

  7. US 9463166

    Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

    RECRO GAINESVILLE LLC · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  8. US 9452175

    Pregnancy hormone combination for treatment of autoimmune diseases

    The Regents of the University of California · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  9. US 9421254

    Immunostimulatory combinations of TLR ligands and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  10. US 9375475

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  11. US 9359313

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  12. US 9320789

    Combinations of gene deletions for live attenuated shigella vaccine strains

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  13. US 9314465

    Drug combinations and uses in treating a coughing condition

    Infirst Healthcare Limited · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  14. US 9308211

    Drug combinations and uses in treating a coughing condition

    Infirst Healthcare Limited · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  15. US 9309535

    Combination anti-HIV vectors, targeting vectors, and methods of use

    The Regents of the University of California · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  16. US 9301920

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  17. US 9302002

    Etanercept formulations stabilized with combinations of sugars and polyols

    Coherus BioSciences, Inc. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  18. US 9289451

    Methods and compositions for targeted cleavage and recombination

    Sangamo Biosciences, Inc. · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  19. US 9273143

    Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EGFR antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  20. US 9243068

    Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases

    VACCINEX, INC. · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  21. US 9198893

    Combination antitumor therapy

    Galera Labs, LLC · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  22. US 9198907

    Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent

    PTC THERAPEUTICS, INC. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  23. US 9138453

    Nutrient combinations for affecting an aging process

    BioMarker Pharmaceuticals, Inc. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  24. US 9114145

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.